IFITM3 and dengue disease: Viperin together with IFITM2 and IFITM3 are reported to have antiviral activity, as processes of binding, entry, and uncoating of the nucleocapsid are considered as targets of IFITM proteins and are inhibited in case of, for example, West Nile and Dengue virus infections [50,51].